BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30015173)

  • 1. A fast method to reprogram and CRISPR/Cas9 gene editing from erythroblasts.
    Melo US; de Souza Leite F; Costa S; Rosenberg C; Zatz M
    Stem Cell Res; 2018 Aug; 31():52-54. PubMed ID: 30015173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of 'designer erythroblasts' lacking one or more blood group systems from CRISPR/Cas9 gene-edited human-induced pluripotent stem cells.
    Pandey P; Zhang N; Curtis BR; Newman PJ; Denomme GA
    J Cell Mol Med; 2021 Oct; 25(19):9340-9349. PubMed ID: 34547166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
    Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
    Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precise and efficient scarless genome editing in stem cells using CORRECT.
    Kwart D; Paquet D; Teo S; Tessier-Lavigne M
    Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous reprogramming and gene editing of human fibroblasts.
    Howden SE; Thomson JA; Little MH
    Nat Protoc; 2018 May; 13(5):875-898. PubMed ID: 29622803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient genome editing in cultured cells and embryos of Debao pig and swamp buffalo using the CRISPR/Cas9 system.
    Su X; Cui K; Du S; Li H; Lu F; Shi D; Liu Q
    In Vitro Cell Dev Biol Anim; 2018 May; 54(5):375-383. PubMed ID: 29556895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines.
    Sanjurjo-Soriano C; Erkilic N; Mamaeva D; Kalatzis V
    Methods Mol Biol; 2022; 2454():589-606. PubMed ID: 33755901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric disease.
    Powell SK; Gregory J; Akbarian S; Brennand KJ
    Mol Cell Neurosci; 2017 Jul; 82():157-166. PubMed ID: 28549865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
    Yumlu S; Bashir S; Stumm J; Kühn R
    Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High efficient multisites genome editing in allotetraploid cotton (Gossypium hirsutum) using CRISPR/Cas9 system.
    Wang P; Zhang J; Sun L; Ma Y; Xu J; Liang S; Deng J; Tan J; Zhang Q; Tu L; Daniell H; Jin S; Zhang X
    Plant Biotechnol J; 2018 Jan; 16(1):137-150. PubMed ID: 28499063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
    Zhang Y; Sastre D; Wang F
    Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
    Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
    Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro CRISPR-Cas9-mediated efficient Ad5 vector modification.
    Tang L; Gong M; Zhang P
    Biochem Biophys Res Commun; 2016 May; 474(2):395-399. PubMed ID: 27125457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 Assisted Multiplex Genome Editing Technique in Escherichia coli.
    Feng X; Zhao D; Zhang X; Ding X; Bi C
    Biotechnol J; 2018 Sep; 13(9):e1700604. PubMed ID: 29790644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-Step Generation of Seamless Luciferase Gene Knockin Using CRISPR/Cas9 Genome Editing in Human Pluripotent Stem Cells.
    Li M; Hunt JFVS; Bhattacharyya A; Zhao X
    Methods Mol Biol; 2019; 1942():61-69. PubMed ID: 30900175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
    Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
    FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones.
    Frank E; Cailleret M; Nelep C; Fragner P; Polentes J; Herardot E; El Kassar L; Giraud-Triboult K; Monville C; Ben M'Barek K
    Stem Cell Res Ther; 2023 Apr; 14(1):110. PubMed ID: 37106426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an Efficient Genome Editing Tool in Bacillus licheniformis Using CRISPR-Cas9 Nickase.
    Li K; Cai D; Wang Z; He Z; Chen S
    Appl Environ Microbiol; 2018 Mar; 84(6):. PubMed ID: 29330178
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous zygotic inactivation of multiple genes in mouse through CRISPR/Cas9-mediated base editing.
    Zhang H; Pan H; Zhou C; Wei Y; Ying W; Li S; Wang G; Li C; Ren Y; Li G; Ding X; Sun Y; Li GL; Song L; Li Y; Yang H; Liu Z
    Development; 2018 Oct; 145(20):. PubMed ID: 30275281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.